The Need for Separate Performance Goals for Glucose Sensors in the Hypoglycemic, Normoglycemic, and Hyperglycemic Ranges
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Blood glucose monitors are an important tool for people with diabetes to assess their physiological status and allow them to properly dose themselves with medication or food. The need to adjust the amount of treatment is greatest when the blood glucose level is in the hypoglycemic range because of the risk of acute brain damage if the condition is not quickly treated. A variety of technologies are available to assist patients with detecting hypoglycemia. How accurate are the various types of technologies at detecting hypoglycemia? Are the new continuous glucose monitoring technologies as accurate as current performance guidelines for home blood glucose monitors specify? In this issue of Diabetes Care , the Diabetes Research in Children Network (DirecNet) collaborative study group concludes (1) that the GlucoWatch G2 Biographer (GW2B) and continuous glucose monitoring systems (CGMSs) do not reliably detect hypoglycemia in children and adolescents. They noted that as few as 31% of GW2B values and as few as 42% of CGMSs (including both first- and second-generation sensors) were within 15 mg/dl of reference serum values. When a hypoglycemia alarm value was set at 60 mg/dl, the GW2B demonstrated that the sensitivity to detect hypoglycemia was 23%, the specificity to detect hypoglycemia was 49%, and the false-alarm incidence was 51%. The two continuous glucose monitors probably performed less accurately in this DirecNet study than many clinicians would expect of new technology that has been approved by the U.S. Food and Drug Administration within the past few years. The performance statistics for glucose monitoring systems that are frequently quoted from the literature or from the package inserts of manufacturers mostly derive from studies that measure patients whose blood glucose levels can be low, normal, or high. Because most patients spend little time in a state of hypoglycemia, the majority of data points …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skeie, S., Thue, G., Nerhus, K., & Sandberg, S. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.7.994 · Cited by 131 · cited 1×
“(15) reported in 2002 that for four of five blood glucose monitors tested, the percentage deviation from a reference method was highest in the hypoglycemic range compared with the normoglycemic and hyperglycemic ranges.”
BackgroundSell-Monitoring of Blood Glucose
(1996) · Diabetes Care · doi:10.2337/diacare.19.1.s62 · Cited by 89
Newer portable glucose meters—analytical improvement compared with previous generation devices?
Weitgasser, R., Gappmayer, B., & Pichler, M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.10.1821 · Cited by 85
Cited by
Ronkainen, N. J., Halsall, H. B., & Heineman, W. R. (2010) · Chemical Society Reviews · doi:10.1039/b714449k · Cited by 1,945
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Self-citationEvaluating the Accuracy of Continuous Glucose-Monitoring Sensors
Kovatchev, B. P., Gonder-Frederick, L. A., Cox, D. J., & Clarke, W. L. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1922 · Cited by 312
“2) CG-EGA judges CGS performance separately at hypoglycemia, euglycemia, and hyperglycemia, “utilizing stratified data according to the magnitude of glycemia,” as advocated by Klonoff (8).”
MethodNon-Invasive Glucose Measurement Technologies: An Update from 1999 to the Dawn of the New Millennium
Khalil, O. S. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2004.6.660 · Cited by 255
Freckmann, G., Schmid, C., Baumstark, A., Pleus, S., Link, M., & Haug, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600510 · Cited by 237
Metadata
- Authors
- Klonoff, D. C.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2004-03-01
- Volume
- 27
- Issue
- 3
- Pages
- 834-836
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2093721906
- Cited by
- 56
- References
- 3
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Need for Separate Performance Goals for Glucose Sensors in the Hypoglycemic, Normoglycemic, and Hyperglycemic Ranges. https://app.cochat.ai/papers/10.2337/diacare.27.3.834
- The paper
- Klonoff, D. C. (2004). The Need for Separate Performance Goals for Glucose Sensors in the Hypoglycemic, Normoglycemic, and Hyperglycemic Ranges. Diabetes Care. https://doi.org/10.2337/diacare.27.3.834
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.